US6753423B1
(en)
|
1990-01-11 |
2004-06-22 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for enhanced biostability and altered biodistribution of oligonucleotides in mammals
|
US6783931B1
(en)
|
1990-01-11 |
2004-08-31 |
Isis Pharmaceuticals, Inc. |
Amine-derivatized nucleosides and oligonucleosides
|
US5578718A
(en)
*
|
1990-01-11 |
1996-11-26 |
Isis Pharmaceuticals, Inc. |
Thiol-derivatized nucleosides
|
US5852182A
(en)
*
|
1990-01-11 |
1998-12-22 |
Isis Pharmaceuticals Inc. |
Thiol-derivatized oligonucleosides
|
US6395492B1
(en)
|
1990-01-11 |
2002-05-28 |
Isis Pharmaceuticals, Inc. |
Derivatized oligonucleotides having improved uptake and other properties
|
US7037646B1
(en)
|
1990-01-11 |
2006-05-02 |
Isis Pharmaceuticals, Inc. |
Amine-derivatized nucleosides and oligonucleosides
|
US6153737A
(en)
*
|
1990-01-11 |
2000-11-28 |
Isis Pharmaceuticals, Inc. |
Derivatized oligonucleotides having improved uptake and other properties
|
US6114513A
(en)
|
1990-01-11 |
2000-09-05 |
Isis Pharmaceuticals, Inc. |
Thiol-derivatized oligonucleotides
|
US6083696A
(en)
*
|
1990-06-11 |
2000-07-04 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands exponential enrichment: blended selex
|
US6465188B1
(en)
|
1990-06-11 |
2002-10-15 |
Gilead Sciences, Inc. |
Nucleic acid ligand complexes
|
US5705337A
(en)
*
|
1990-06-11 |
1998-01-06 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-SELEX
|
US5962219A
(en)
|
1990-06-11 |
1999-10-05 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-selex
|
US6011020A
(en)
*
|
1990-06-11 |
2000-01-04 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligand complexes
|
US6147204A
(en)
*
|
1990-06-11 |
2000-11-14 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligand complexes
|
US5683867A
(en)
*
|
1990-06-11 |
1997-11-04 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: blended SELEX
|
US5723289A
(en)
*
|
1990-06-11 |
1998-03-03 |
Nexstar Pharmaceuticals, Inc. |
Parallel selex
|
US6465189B1
(en)
|
1990-06-11 |
2002-10-15 |
Gilead Sciences, Inc. |
Systematic evolution of ligands by exponential enrichment: blended selex
|
US6030776A
(en)
*
|
1990-06-11 |
2000-02-29 |
Nexstar Pharmaceuticals, Inc. |
Parallel SELEX
|
US6168778B1
(en)
|
1990-06-11 |
2001-01-02 |
Nexstar Pharmaceuticals, Inc. |
Vascular endothelial growth factor (VEGF) Nucleic Acid Ligand Complexes
|
US7119184B2
(en)
|
1991-08-12 |
2006-10-10 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having A-DNA form and B-DNA form conformational geometry
|
EP1331011A3
(de)
*
|
1991-10-24 |
2003-12-17 |
Isis Pharmaceuticals, Inc. |
Derivatisierte Oligonukleotide mit verbessertem Aufnahmevermögen.
|
US6831166B2
(en)
|
1992-10-23 |
2004-12-14 |
Isis Pharmaceuticals, Inc. |
Derivatized oligonucleotides having improved uptake and other properties
|
US5693769A
(en)
*
|
1991-12-13 |
1997-12-02 |
Transcell Technologies, Inc. |
Glycosylated steroid derivatives for transport across biological membranes and process for making and using same
|
US5795870A
(en)
*
|
1991-12-13 |
1998-08-18 |
Trustees Of Princeton University |
Compositions and methods for cell transformation
|
US5780444A
(en)
*
|
1991-12-13 |
1998-07-14 |
Trustees Of Princeton University |
Compositions and methods for cell transformation
|
US6020482A
(en)
*
|
1992-05-25 |
2000-02-01 |
Gosselin; Gilles |
Phosphotriester type biologically active compounds
|
FR2691463A1
(fr)
*
|
1992-05-25 |
1993-11-26 |
Centre Nat Rech Scient |
Dérivés nucléotidiques, leur préparation et leur application en thérapeutique.
|
US5849905A
(en)
*
|
1994-11-23 |
1998-12-15 |
Centre National De La Recherche Scientifique |
Biologically active phosphotriester-type nucleosides and methods for preparing same
|
US5770725A
(en)
*
|
1992-05-25 |
1998-06-23 |
Gosselin; Gilles |
Phosphotriester type biologically active compounds
|
FR2692265B1
(fr)
*
|
1992-05-25 |
1996-11-08 |
Centre Nat Rech Scient |
Composes biologiquement actifs de type phosphotriesters.
|
US5607691A
(en)
*
|
1992-06-12 |
1997-03-04 |
Affymax Technologies N.V. |
Compositions and methods for enhanced drug delivery
|
WO1994023751A1
(de)
*
|
1993-04-14 |
1994-10-27 |
Boehringer Mannheim Gmbh |
Nukleinsäure-transferpeptide und deren verwendung zur einschleusung von nukleinsäuren in eukaryontische zellen
|
US5955591A
(en)
*
|
1993-05-12 |
1999-09-21 |
Imbach; Jean-Louis |
Phosphotriester oligonucleotides, amidites and method of preparation
|
US5580972A
(en)
*
|
1993-06-14 |
1996-12-03 |
Nexstar Pharmaceuticals, Inc. |
Purine nucleoside modifications by palladium catalyzed methods
|
US5719273A
(en)
*
|
1993-06-14 |
1998-02-17 |
Nexstar Pharmaceuticals, Inc. |
Palladium catalyzed nucleoside modifications methods using nucleophiles and carbon monoxide
|
US6653458B1
(en)
|
1993-09-03 |
2003-11-25 |
Isis Pharmaceuticals, Inc. |
Modified oligonucleotides
|
US5998142A
(en)
*
|
1993-09-08 |
1999-12-07 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-SELEX
|
AU7564194A
(en)
*
|
1993-09-10 |
1995-03-27 |
University Of Medicine And Dentistry Of New Jersey |
Blood-brain barrier transporters of neurological agents
|
DE4437502A1
(de)
*
|
1993-12-02 |
1995-06-08 |
Basf Ag |
Hirudin-Konjugate aus Hirudin und lipophilen Verbindungen
|
US5830686A
(en)
*
|
1994-01-13 |
1998-11-03 |
Calydon |
Tissue-specific enhancer active in prostate
|
US6057299A
(en)
*
|
1994-01-13 |
2000-05-02 |
Calydon, Inc. |
Tissue-specific enhancer active in prostate
|
DE4421079C1
(de)
*
|
1994-06-16 |
1995-08-17 |
Peter Dr Rer Nat Seibel |
Chimäres Peptid-Nukleinsäure-Fragment, Verfahren zu seiner Herstellung und die Verwendung des Fragments zur zielgerichteten Nukleinsäureeinbringung in Zellorganellen und Zellen
|
US6048698A
(en)
*
|
1994-09-20 |
2000-04-11 |
Nexstar Pharmaceuticals, Inc. |
Parallel SELEX™
|
US5627185A
(en)
*
|
1994-11-23 |
1997-05-06 |
Gosselin; Gilles |
Acyclovir derivatives as antiviral agents
|
AU5259796A
(en)
|
1995-02-10 |
1996-08-27 |
Worcester Foundation For Biomedical Research, Inc. |
Delivery of exogenous compounds
|
WO1996030536A1
(en)
*
|
1995-03-24 |
1996-10-03 |
Board Of Regents, The University Of Texas System |
Egf-targeted nucleic acid delivery
|
US5859228A
(en)
*
|
1995-05-04 |
1999-01-12 |
Nexstar Pharmaceuticals, Inc. |
Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
|
US8071737B2
(en)
|
1995-05-04 |
2011-12-06 |
Glead Sciences, Inc. |
Nucleic acid ligand complexes
|
US6229002B1
(en)
|
1995-06-07 |
2001-05-08 |
Nexstar Pharmaceuticlas, Inc. |
Platelet derived growth factor (PDGF) nucleic acid ligand complexes
|
US5959100A
(en)
|
1996-03-27 |
1999-09-28 |
Nexstar Pharmaceuticals, Inc. |
Pyrimidine nucleosides as therapeutic and diagnostic agents
|
US5945527A
(en)
*
|
1996-05-30 |
1999-08-31 |
Nexstar Pharmaceuticals, Inc. |
Palladium catalyzed nucleoside modification methods using nucleophiles and carbon monoxide
|
US6838238B1
(en)
|
1996-10-17 |
2005-01-04 |
Invitrogen Corporation |
Morphatides: novel shape and structure libraries
|
US6051698A
(en)
*
|
1997-06-06 |
2000-04-18 |
Janjic; Nebojsa |
Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
|
US6426335B1
(en)
|
1997-10-17 |
2002-07-30 |
Gilead Sciences, Inc. |
Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
|
US5925628A
(en)
*
|
1997-03-31 |
1999-07-20 |
Genzyme Corporation |
Cationic amphiphiles for intracellular delivery of therapeutic molecules
|
US5912239A
(en)
*
|
1997-04-04 |
1999-06-15 |
Genzyme Corporation |
Imidazole-containing cationic amphiphiles for intracellular delivery of therapeutic molecules
|
US5948925A
(en)
*
|
1997-05-06 |
1999-09-07 |
Genzyme Corporation |
Cationic amphiphiles containing linkers derived from neutral or positively charged amino acids
|
US5952516A
(en)
*
|
1997-05-08 |
1999-09-14 |
Genzyme Corporation |
Cationic amphiphiles containing multiplesteroid lipophilic groups
|
US5942634A
(en)
*
|
1997-05-09 |
1999-08-24 |
Genzyme Corporation |
Cationic amphiphiles for cell transfections
|
US6025140A
(en)
*
|
1997-07-24 |
2000-02-15 |
Perseptive Biosystems, Inc. |
Membrane-permeable constructs for transport across a lipid membrane
|
WO1999006576A1
(en)
|
1997-08-04 |
1999-02-11 |
Calydon, Inc. |
A human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof
|
IL137247A0
(en)
|
1998-01-30 |
2001-07-24 |
Aventis Pharma Sa |
Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
|
US6531590B1
(en)
*
|
1998-04-24 |
2003-03-11 |
Isis Pharmaceuticals, Inc. |
Processes for the synthesis of oligonucleotide compounds
|
US6169078B1
(en)
*
|
1998-05-12 |
2001-01-02 |
University Of Florida |
Materials and methods for the intracellular delivery of substances
|
AU5346299A
(en)
*
|
1998-08-26 |
2000-03-21 |
Nexstar Pharmaceuticals, Inc. |
Du site-directed cleavage of covalent conjugates
|
US6020483A
(en)
|
1998-09-25 |
2000-02-01 |
Nexstar Pharmaceuticals, Inc. |
Nucleoside modifications by palladium catalyzed methods
|
EP1155056A4
(de)
*
|
1998-12-04 |
2004-05-12 |
Mosaic Technologies Inc |
Verfahren zur immobilisierung von oligonucleotiden
|
US6121437A
(en)
*
|
1999-03-16 |
2000-09-19 |
Isis Pharmaceuticals, Inc. |
Phosphate and thiophosphate protecting groups
|
US8106098B2
(en)
|
1999-08-09 |
2012-01-31 |
The General Hospital Corporation |
Protein conjugates with a water-soluble biocompatible, biodegradable polymer
|
US6822086B1
(en)
|
1999-08-09 |
2004-11-23 |
The General Hospital Corporation |
Drug-carrier complexes and methods of use thereof
|
WO2005041859A2
(en)
|
2003-04-30 |
2005-05-12 |
Sirna Therapeutics, Inc. |
Conjugates and compositions for cellular delivery.
|
US6749865B2
(en)
|
2000-02-15 |
2004-06-15 |
Genzyme Corporation |
Modification of biopolymers for improved drug delivery
|
WO2001060412A2
(en)
|
2000-02-15 |
2001-08-23 |
Genzyme Corporation |
Modification of biopolymers for improved drug delivery
|
US6706474B1
(en)
|
2000-06-27 |
2004-03-16 |
Board Of Trustees Of The University Of Illinois |
Nucleic acid enzyme biosensors for ions
|
US6559279B1
(en)
*
|
2000-09-08 |
2003-05-06 |
Isis Pharmaceuticals, Inc. |
Process for preparing peptide derivatized oligomeric compounds
|
NZ511705A
(en)
*
|
2001-05-14 |
2004-03-26 |
Horticulture & Food Res Inst |
Methods and rapid immunoassay device for detecting progesterone and other steroids
|
US7109165B2
(en)
|
2001-05-18 |
2006-09-19 |
Sirna Therapeutics, Inc. |
Conjugates and compositions for cellular delivery
|
US20030113714A1
(en)
*
|
2001-09-28 |
2003-06-19 |
Belcher Angela M. |
Biological control of nanoparticles
|
US20030148380A1
(en)
|
2001-06-05 |
2003-08-07 |
Belcher Angela M. |
Molecular recognition of materials
|
AU2002359761A1
(en)
|
2001-12-18 |
2003-06-30 |
Invenux, Inc. |
Antibiotic compounds
|
SE0201234D0
(sv)
*
|
2002-04-24 |
2002-04-24 |
Avaris Ab |
Transfer complex with added functionality and methods for its use
|
US6890719B2
(en)
|
2002-05-10 |
2005-05-10 |
The Board Of Trustess Of The University Of Illinois |
Fluorescence based biosensor
|
US20050064508A1
(en)
|
2003-09-22 |
2005-03-24 |
Semzyme |
Peptide mediated synthesis of metallic and magnetic materials
|
US8853376B2
(en)
|
2002-11-21 |
2014-10-07 |
Archemix Llc |
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
|
US6913890B2
(en)
|
2002-12-18 |
2005-07-05 |
Palo Alto Research Center Incorporated |
Process for preparing albumin protein conjugated oligonucleotide probes
|
US7816337B2
(en)
|
2003-02-18 |
2010-10-19 |
Roche Madison Inc. |
Reversible attachment of a membrane active polymer to a polynucleotide
|
AU2004271215B2
(en)
*
|
2003-09-09 |
2009-07-16 |
Geron Corporation |
Modified oligonucleotides for telomerase inhibition
|
EP1695717A1
(de)
*
|
2005-02-23 |
2006-08-30 |
Ludwig-Maximilians-Universität |
Transport Nano- und Makromolecularer Strukturen ins Zytoplasma und in den Zellkern
|
US7892734B2
(en)
|
2005-08-11 |
2011-02-22 |
The Board Of Trustees Of The University Of Illinois |
Aptamer based colorimetric sensor systems
|
WO2007109500A1
(en)
|
2006-03-16 |
2007-09-27 |
The Board Of Trustees Of The University Of Illinois |
Lateral flow devices
|
EP2046964B1
(de)
*
|
2006-07-12 |
2018-07-04 |
The Regents of The University of California |
Transduzierbare zuführung von nukleinsäuren durch reversible phosphotriesterladungsneutralisierungs-schutzgruppen
|
WO2008089248A2
(en)
*
|
2007-01-19 |
2008-07-24 |
The Board Of Trustees Of The University Of Illinois |
Amphiphilic substances and triggered liberation from lipid vesicles
|
WO2008094640A2
(en)
|
2007-01-30 |
2008-08-07 |
Geron Corporation |
Compounds having anti-adhesive effects on cancer cells
|
US8058415B2
(en)
|
2007-04-24 |
2011-11-15 |
The Board Of Trustees Of The University Of Illinois |
Aptamer- and nucleic acid enzyme-based systems for simultaneous detection of multiple analytes
|
US8409800B2
(en)
|
2007-07-16 |
2013-04-02 |
The Board Of Trustees Of The University Of Illinois |
Nucleic acid based fluorescent sensor for copper detection
|
US8568690B2
(en)
|
2007-07-31 |
2013-10-29 |
The Board Of Trustees Of The University Of Illinois |
MRI contrast agents and high-throughput screening by MRI
|
WO2009045632A2
(en)
|
2007-08-10 |
2009-04-09 |
The Board Of Trustees Of The University Of Illinois |
Nucleic acid based fluorescent sensor for mercury detection
|
US8062893B2
(en)
|
2008-10-10 |
2011-11-22 |
The Board Of Trustees Of The University Of Illinois |
Fluorescent sensor for mercury
|
SG184497A1
(en)
|
2010-04-12 |
2012-11-29 |
Somalogic Inc |
5-position modified pyrimidines and their use
|
WO2011161075A1
(en)
|
2010-06-22 |
2011-12-29 |
Dna Therapeutics |
Optimized in vivo delivery system with endosomolytic agents for nucleic acid conjugates
|
US8815156B2
(en)
|
2010-07-19 |
2014-08-26 |
Andalyze, Inc. |
Sensor housing and reagent chemistry
|
EP2527440A1
(de)
*
|
2011-05-27 |
2012-11-28 |
Institut Curie |
Krebsbehandlung durch Kombination von Doppelstrangbruch nachahmenden DNA-Molekülen mit Hyperthermie
|
IN2015DN01765A
(de)
|
2012-08-20 |
2015-05-29 |
Univ California |
|
CN106061981A
(zh)
*
|
2013-11-06 |
2016-10-26 |
索尔斯蒂斯生物有限公司 |
具有二硫化物基团的多核苷酸构建体
|
JOP20200257A1
(ar)
|
2014-05-01 |
2017-06-16 |
Geron Corp |
تركيبات أوليجو نوكليوتيد وطرق لتحضيرها
|
KR101896567B1
(ko)
|
2015-07-23 |
2018-09-07 |
인스티튜트 큐리 |
암 치료를 위한 디베이트 분자와 parp 억제제의 병용 용도
|
JP2019532027A
(ja)
|
2016-08-17 |
2019-11-07 |
ソルスティス バイオロジクス,リミティッド |
ポリヌクレオチド構築物
|
MX2019002075A
(es)
|
2016-08-23 |
2019-07-01 |
Dicerna Pharmaceuticals Inc |
Composiciones que comprenden oligonucleotidos modificados reversiblemente, y sus usos.
|
EP3645546A4
(de)
|
2017-06-30 |
2021-12-01 |
Solstice Biologics, Ltd. |
Chirale phosphoramidithilfsmittel und verfahren zu ihrer verwendung
|
EP3674407A4
(de)
*
|
2017-08-22 |
2022-01-12 |
National University Corporation Nagoya University |
Modifiziertes polynukleotid
|